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ABSTRACT
Analysis of the Nucleocapsid Protein of IBV and its Association with
a Hypervariable Region in the 3' End of the Genome.
(May 1993)
Anna K. Williams, B.S. University of Reading, U. K.
Chair of Advisory Committee: Dr. Ellen Collisson
The natural sequence variations of the nucleocapsid genes and 3' non¬
coding regions of the Gray, Ark99 and Holl52 strains of IBV were determined
and compared to the Mass41, Beau and KB8523 strains. The nucleocapsid
protein was highly conserved and also shared conserved amino acids with
other coronaviruses. In contrast, the 3' non-coding region contained a U-rich
hypervariable region (HVR) immediately downstream of the nucleocapsid
gene. This U-rich sequence was absent from 3' non-coding region of the
Mass41 strain, and was also highly variable, especially in comparison to the
highly conserved 3’ non-coding region downstream of this sequence.
Computer analyses of the sequences within and adjacent to this HVR
showed that the 3’ end of the genome was highly conserved downstream of
this region, with 94.3 to 97.8% similarity. However, the similarities for the
HVR ranged from 53.2% between Holl52 and Ark99, to 92.8% between
Beaudette and Gray. The flanking sequences upstream and downstream of
the HVR were conserved and also formed mirrored images. The association
of the IBV nucleocapsid protein with RNA from portions of the 3' end of the
genome was examined by northwestern blot analysis and gel shift assays.
The present studies have shown that the nucleocapsid protein was able to
bind with a high affinity to RNA corresponding to the 3’ end of the IBV
genome. All the positive and negative sense IBV-derived RNAs used in this
study were capable of binding to the nucleocapsid protein, and apparently
all the positive sense IBV RNAs had similar affinity for the nucleocapsid
protein.
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CHAPTER I
INTRODUCTION
Avian infectious bronchitis virus (IBV), the prototype of the
Coronaviridae, causes an acute, highly contagious respiratory disease in
chickens. Infection with IBV results in morbidity and sometimes mortality, but
although significant economic losses result from the reduction in egg quality
and production in laying flocks, the greatest losses result from condemnation
of broilers (Cunningham, 1970; King & Cavanagh, 1991). The disease was
first described by Schalk and Hawn in 1931, the causative agent was found
to be a virus in 1936 (Beach and Schalm) and this virus was first cultivated
in embryonating chicken eggs in 1937 (Beaudette and Hudson).
Members of the Coronaviridae family were first classified as a group
on the basis of negative stains examined by electron microscopy (Berry et
al., 1964; Almeida et al., 1967). Large club-shaped surface projections, also
called spikes or peplomers, create the distinct crown-like or corona
appearance observed with the electron microscope. The virions are roughly
spherical and somewhat pleomorphic, with an estimated diameter of 90-
200nm and spikes of 20nm (Davis et al., 1979; Sturman & Holmes, 1983). A
bilipid envelope of cell membrane origin surrounds the nucleocapsid of the
virion making the virion sensitive to solvents such as chloroform (Otsuki et
al., 1979).
The format of this dissertation follows that of Virology.
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Two glycosylated proteins are integrated into the envelope
membrane of IBV: the large multimeric spike protein (S) and the membrane
protein (M) (Cavanagh, 1981). This envelope surrounds a helical
nucleocapsid consisting of an RNA genome associated with a number of
copies of the third major structural protein, the nucleocapsid protein (N)
(Schochetman eta!., 1977; Oshiro, 1973).
The IBV genome consists of single stranded, polyadenylated RNA
(Shochetman et al., 1977), is 27.6kb in length and was the first Coronavirus
to be completely sequenced (Boursnell et al., 1987). The genomic RNA is
infectious as it can act directly in the cell as a viral mRNA, initiate replication
in the absence of viral proteins and result in production of viable virus
progeny (Schochetman et al., 1977; Lomniczi, 1977). In addition to the
complete genome which functions as a mRNA for putative polymerase
activity, infected cells have five subgenomic mRNAs which form a 3' co¬
terminal nested set; that is, the entire sequence of each species is found in
the larger species (Stern et al., 1982; Boursnell et al., 1987). These mRNAs
are numbered from 1 to 6 with RNA 1 being the largest or genomic RNA and
RNA 6 being the smallest sub-genomic RNA. A common leader sequence
of about 60 bases is found at the 5' end of each sub-genomic mRNA, as well
as the genomic RNA (Brown et al., 1984).
In most cases, the IBV proteins are produced by translation of the
open reading frame (ORF) located at the 5' end of each of the mRNAs (Stern
and Kennedy, 1980). RNA 1, the genomic RNA, codes for the polymerase-
associated proteins, RNA 2 encodes the spike protein, RNA 4, the
membrane protein, and RNA 6, the nucleocapsid protein (Fig. 1-1).
However, RNA 3 has 3 ORFs and the third ORF has been found to encode a
Fig.1-1
F2D13CB2 I s□D2DmBidN ai□□
GenomeoPolymerase mRNA1DPolymerase mRNA2nSpike mRNA3D3CProtein mRNA4nMembrane mRNA5°(B1/B2) mRNA6nNucleocapsid 27.6109876543Okb Schematicrepresentat onoft penr adingf a esfIBVmRNA .Ths allboxt5’ df eachRNArepresentsthlead rsequence.
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membrane-associated protein of 12.4kD that is found in infected cells (Smith
etal., 1990). RNA 5 contains 2 ORFs but no proteins corresponding to these
ORFs have been found in either the virion or infected cells (Boursnell and
Brown, 1984).
Viral replication takes place under the control of a viral RNA-
dependent RNA polymerase, which is produced as a large polyprotein by
translation of the genomic RNA upon entry of the virus into the cell. This
polymerase (or a subunit of the polyprotein) then presumably recognizes the
3' end of the genomic RNA and initiates transcription, resulting in the
production of either full-length negative sense RNA, or negative sense
subgenomic RNAs, from which mRNAs can be transcribed (Boursnell etal,
1987; Sethna et a/., 1989). The leader sequence found at the 5' end of
genomic RNA is thought to play a role in transcription. Excess copies of the
leader sequence are made from the full length negative RNA and are then
able to recognize a sequence upstream of the ORFs and act as a primer for
transcription.
The IBV nucleocapsid protein is a highly basic, phosphorylated
protein of 409 amino acids and relative molecular weight of approximately
50kD. The nucleocapsid protein of coronaviruses is closely associated with
the RNA genome, has been shown to be involved in transcription of murine
hepatitis virus (MHV) (Nakanaga etal, 1986) and may also be involved in
translation (Compton et al, 1987). A 140kD trimer of the nucleocapsid
protein of MHV has been found in non-reduced preparations of purified
virions suggesting the presence of disulphide linked multimers (Robbins et
al, 1986).
Although coronaviruses are the only positive sense RNA viruses
known to have a helical nucleocapsid, several negative sense RNA viruses
have helical nucleocapsids that are important in regulating viral transcription
(Arnheiter et al., 1985; Banerjee, 1987). The nucleocapsid protein of MHV
has been found to be bound to cytosol and membrane-bound small leader
RNAs, as well as to transcription complexes. Also, anti-N monoclonal
antibodies precipitate both full length and subgenomic mRNAs as well as
replicative intermediate (Rl) RNAs (Baric et al., 1988a). Baric et al. (1988b)
have also shown a specific nucleocapsid protein recognition sequence
exists in the small leader-containing RNAs, suggesting that a trans-acting
leader RNA-N complex is involved with mRNA synthesis.
It is known that several copies of the nucleocapsid protein of IBV are
associated with the RNA (Schochetman et al., 1977; Oshiro, 1973) and, as
transcription of the negative template is initiated at the 3’ end of the genomic
RNA, it seems possible that this is another region where the nucleocapsid
protein binds and plays a role in transcription.
Coronaviruses have been shown to fall into three antigenic groups.
Human coronavirus (HCV)-229E, transmissible gastroenteritis virus (TGEV),
canine coronavirus (CCV), feline enteric coronavirus (FECV), and feline
infectious peritonitis virus (FIPV) belong to group I, HCV-OC43, murine
hepatitis virus (MHV), turkey coronavirus (TCV) and bovine coronavirus
(BCV) to group II, and IBV alone to group III (Dea et al., 1991). Although
antigenicity is generally based on the spike protein, the nucleocapsid
protein is also highly immunogenic and is produced in large quantities
during replication (Cavanagh, 1983; Sneed et al., 1989). It has also been
shown that the nucleocapsid protein, in association with the MHC II, is
recognized by T-cell hybridomas and that there is some antigenic variation
among nucleocapsid proteins of IBV (Boots et al., 1991). As such, the
nucleocapsid protein may be a useful component of a synthetic vaccine.
The present study has focused on the investigation of the
conservation of the IBV nucleocapsid gene and its relationship to other
coronaviruses, the sequence variations and resulting secondary structures
of the IBV 3' non-coding region, and the binding of the nucleocapsid protein
to certain sequences in the 3' end of the IBV genome.
CHAPTER II
COMPARATIVE ANALYSIS OF THE NUCLEOCAPSID GENES OF
SEVERAL STRAINS OF IBV AND OTHER CORONAVIRUSES
Introduction
Avian infectious bronchitis virus (IBV) is a highly contagious pathogen
of chickens. IBV infection is characterized by tracheal rales, coughing and
sneezing, and can also cause lesions in the reproductive tract and kidneys
(Darbyshire et al., 1979). IBV was the first coronavirus to be described
(Schalk & Hawn, 1931), and many strains varying widely in virulence,
serotype and pathotype have been identified (Cumming, 1963; Darbyshire
et al., 1979). Beaudette is a highly attenuated strain of IBV, Holland52
(Holl52) is a vaccine strain, Gray and a Japanese strain (KB8523) are both
known to be nephropathogenic but have also been associated with
respiratory disease, and Ark99 (Arkansas 99) and Mass41 are generally
thought to result in severe respiratory disease in the absence of gross
kidney lesions. (Beaudette & Hudson, 1937; Cumming, 1963; Darbyshire et
al., 1979; Johnson & Marquardt, 1986; Jungherr et al., 1956; Sutou et al.,
1988; Winterfield & Hitchener, 1962).
IBV is the prototype of the family Coronaviridae and was the first
coronavirus to be completely sequenced. The IBV genome is 27.6kb in
length and consists of single-stranded RNA of positive polarity with a polyA
tail (Boursnell et al., 1987). The infectious virion has at least three structural
proteins (Siddell et al., 1983; Stern et al., 1982); the glycosylated spike
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protein, which is responsible for the corona-like appearance of the virions,
the membrane protein, and the nucleocapsid protein which is associated
with the genome and is encoded by a gene at the 3' end of the genome.
Coronaviruses have been shown to fall into three antigenic groups
based on serotype. Human coronavirus-229E (HCV-229E), transmissible
gastroenteritis virus (TGEV), canine coronavirus (CCV), feline enteric
coronavirus (FECV), and feline infectious peritonitis virus (FIPV) belong to
group I, HCV-OC43, murine hepatitis virus (MHV), turkey coronavirus (TCV),
and bovine coronavirus (BCV) to group II, and IBV alone to group III (Dea et
a!., 1990). Although serotyping is generally based on the spike protein, the
nucleocapsid protein is also highly immunogenic and is produced in large
quantities during replication (Sneed et al., 1989; Cavanagh, 1983). It has
also been shown that the nucleocapsid protein in association with the MHC
II is recognized by T-cell hybridomas and that there is some antigenic
variation among nucleocapsid proteins of IBV (Boots et al., 1991). As such,
the nucleocapsid protein may be a useful component of a synthetic vaccine.
The nucleocapsid protein of coronaviruses is closely associated with the
RNA genome, has been shown to be involved in transcription of MHV, and
may also be involved in translation (Compton et al., 1987).
In this study, we have analyzed the overall relatedness of the
nucleotide and amino acid sequences of the nucleocapsid genes of the
Gray, Ark99 and Holl52 strains of IBV, and the published sequences for
Mass41, Beaudette and a Japanese strain, KB8523 (Boursnell et al., 1985,
Sutou et al., 1988). In order to determine the serological and evolutionary
relationship of coronaviruses and the physical and biochemical properties of
the nucleocapsid protein, we have also compared the nucleocapsid protein
of IBV with a number of coronaviruses from the other antigenic groups.
Materials and Methods
Viral Preparation
The viral isolates used in this study were propagated at 37°C for 36-
48h following allantoic sac inoculation into 11-day old specific pathogen free
embryonating chicken eggs (ECE). The eggs were then refrigerated at 4°C
for 5h, and allantoic fluid collected and clarified by centrifugation at 16K x g
for 20 min. Virus was precipitated overnight with 8% polyethylene-glycol,
2.33% NaCI, and concentrated by centrifugation at 16K x g for 20 min. Virus
pellets were reconstituted in 1/50 vol 20mM Tris, 1mM EDTA, 100mM NaCI,
pH7.4 and banded on a 30-50% glycerol/potassium tartrate gradient for 2h
at 100K x g. After concentrating by ultracentrifugation at 100K x g for 1 h,
virus pellets were resuspended in 0.1 M NaOAc, pH5.2, and the virions were
disrupted with 1 mg/ml proteinase K and 1% SDS at 37°C for 1h. The RNA
was extracted first with phenol and then with chloroform/isoamyl alcohol
followed by ethanol precipitation (Wang et al., 1988). Presence of IBV
genomic RNA was confirmed by electrophoresis of a sample of the RNA on a
1% agarose gel and the remaining RNA was reprecipitated with ethanol.
Cloning of the Gray, Ark99 and Holl52 Strains
Purified RNA was pelleted and dried in a Savant vacuum drier. RNA
was resuspended in 7pl deionized H2O (dh^O) and denatured in 6mM
methyl mercuric hydroxide for 10 min at room temperature. First strand
cDNA synthesis was carried out using 5 units of AMV reverse transcriptase
(BMB, Indianapolis, In) at 42°C for 2h in the presence of 14mM 2-
mercaptoethanol (2ME), 50mM Tris pH8.3, 50mM KCI, 8mM MgCl2, 0.8mM
dNTP, 20pg/ml of 3’ end primer (5’ GGATCCGCTCTAACTCTATACTA
GCCTAT 3') and 20 units of RNasin (Promega, Madison, Wi). Following
phenol extraction and ethanol precipitation of the RNA/cDNA hybrid, the
RNA was eliminated by exposure to highly alkaline conditions at 37°C for
3h. The cDNA was then neutralized, concentrated by ethanol precipitation,
and amplified using the polymerase chain reaction (PCR).
PCR was performed with the same 3' end primer as above and a
primer from the upstream intergenic region (5' GAATTCCCGCGTGTACC
TCTCTAG TA 3’) in the presence of 4mM dNTP, 1x Taq buffer (1.5mM
MgCI2, 50mM KCI,10mM Tris-HCI, pH8) and 0.5|il Taq polymerase (Perkin
Elmer, Norwalk, Ct.)- The PCR was performed with a primary denaturation
step at 95°C for 3 min, annealing at 50°C for 30s, extension at 72°C for 1
min, and subsequent denaturation steps at 95°C for 1 min. A total of 30
cycles were used with a final extension step of 3 min at 72°C. Resulting PCR
products were cloned into the pCRIOOO vector, utilizing the single T
overhang at the insertion site (Invitrogen, San Diego, Ca) and sequenced
using Sequenase (USB, Cleveland, Ohio).
Computer Analysis
Resulting sequences were analyzed using the Genbank programs.
Nucleotide sequences were processed using the Seqed program and the
corresponding nucleocapsid protein amino acid sequences were derived by
the Translate program. Comparisons of nucleotide and amino acid
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sequences were made using Gap and Bestfit. IBV sequences were aligned
and displayed using Pileup and Publish, with Gray set as the reference
sequence. A hydrophobicity plot of the nucleocapsid protein of IBV was
determined using the program Pepplot. Other coronavirus sequences were
also aligned using Pileup, with the output being displayed either as a
sequence alignment using Publish, or as a phylogenetic tree using the
Macintosh program PAUP, version 3.0.
Results
Comparison of the nucleotide and amino acid sequences of the
nucleocapsid protein of various strains of IBV
In order to analyze the natural variation among IBV nucleocapsid
proteins and genes, sequencing data of the nucleocapsid genes of Ark99,
Gray and Holl52 were obtained and compared to other coronavirus
sequences. At least two clones of each strain were obtained and these were
sequenced in both directions. Fig. 2-1 shows the nucleotide sequences of
the Gray, Ark99, and Holl52 nucleocapsid genes aligned with the published
sequences of Beaudette, Mass41 and KB8523. This alignment indicates that
overall the sequences are highly conserved with some regions showing no
variation at all. Table 2-1 shows that the percent similarity of the nucleotide
sequences encoding the nucleocapsid protein ranges from 90.9 between
Mass41 and Holl52, to 96.5% between Ark99 and Gray.
The complete open reading frame (ORF) for the nucleocapsid gene of
Gray, Ark99 and Holl52, as well as Beaudette, Mass41 and KB8523,
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GRAY ARK99 HOLL52 BEAUX) MASS41 KB8523
ATGGCAAGCGGTAAGGCAACTGGAAAGACAGACGCCCCAGCGCCAGTCATCAAACTAGGAGGAC GCCACCTAA GT TTCTTCTGGAAATG ATCTTGGTTTCAAGC TA AACCAAG AGCTA TTCACCTCAACC AGT T A GTAGC GT TTCC G AATGA A AA AA A
A AT
GRAY ARK99 HOLL52 BEAUD MASS41 KB8523
AATTTTAAAACAAGCCAGCAACACGGATACTGGAGACGCCAAGCCAGGmAAGCCAGGTAAAGGGCGAAGA A TCC GATGCnGGTACTT TATT TA T AACAGG CCAGCC C GACTT TTGGG G T GCC AGA TA AG G GGGTTGCTGC A G T TC T
GRAY ARK99 HOLLS2 BEAUD MASS41 KB8523
GCTGATGTTAAATCTAGATCTAATCAGGGTACAAGGGACCCTGACAAGTTTGACCAATACC GCTACGATTCTCGGACGGAGGA CT ATGGT TTTCCGTTG GACTTCATTCCT IGAATCGTG TAGGAG A TC A AGCA C TCA CAG AGCATCT AGA ACCG T AT TCAT TC TA
GRAY ARK99 HOLL52 BEAUD MASS41 KB8523
TCGCGTGAAGGCTCGCGTGGTCGTAGAAGTGGITCTGAAGATGATCTTATTGCTCGTGCAGC A ATAAT CAGGAT AGCAG AGAAGGG ICTC CATI CTAAGGCTAAG CTGATG A GGCTCATCG C GT TT C A G A T C ACCT G T TAA T GATCAA
GRAY ARK99 HOLL52 BEAUD MASS41 KB8523
GTTTTTGGTCCCCGTACTAAAGGTAAGGAGGGAAATTTTGGTGATGACAAGATGAATGAGAAGGTAT AAGGA GGGCGT TTACGGCAATGCTCAACCTAGTCCCTAGCA CCATGCCTG CT rT GGAA AGT ACGCCC AACTTCAAC AG TG G T CTTGA ATTT CAT
GRAY ARK99 HOLL52 BEAUD MASS41 KB8523
GAATTTACCACTGTGGTCCCACGTGATGATCCGCAGTrTGATAATTATGTGAAAATTTGTTCAGTGTGT AT GTGTAG GACACG AAAAGA CG ACCAAAACCAAAGTCACGCTCAA T AGA CTGC ACAAGAACAA TTCTCC G CAAGACAACAG GCCT G G
TA
c c
GRAYAAGAAGGAGAAAAGGCCAAAGAAACAGGATGACGAAGTGGATAAAGCATTGACCTCAGATG AG C AT AC GCTGGA TTTGATGATG ACCCAAGGTTATTAACTGGGGGATTCT CTT AG TGA T A C A ARK99GTGGA HOLL52GATT GCGAACTATGA BEAUDATGTCAGG CAT MASS41GTTGAGACAT KB8523ATGAGC ACT
Fig.2-1Nucleotidesequencomparisonfthnucleocapsidg neixtraiIBV
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Table 2-1 Percent homologies of the nucleic acid sequences of the
nucleocapsid genes of six strains of IBV.
Gray Ark99 HOII52 Beaud Mass41 KB8523
Gray 100 96.5 92.8 92.6 93.1 96.3
Ark99 100 93.3 92.6 93.6 94.1
Holl52 100 91.1 90.9 91.8
Beaud 100 93.2 91.2
Mass41 100 92.0
KB8523 100
Table 2-2 Percent homologies of the amino acid sequences of the
nucleocapsid protein of six strains of IBV.
Gray Ark99 HOII52 Beaud Mass41 KB8523
Gray 100 95.1 94.9 94.9 97.1 97.1
Ark99 100 95.4 94.6 95.9 95.9
Holl52 100 94.4 95.4 95.4
Beaud 100 96.3 96.6
Mass41 100 98.3
KB8523 100
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consists of 1227 bases, contains Kozac's consensus sequence at the AUG
start codon (Kozac, 1986) and codes for a basic protein of 409 amino acids.
Two way comparisons among the nucleocapsid proteins of these six strains
of IBV indicate that the similarities range from 94.4 to 98.3%, with Beaudette
and Holl52 having the least similarity, and Gray and Ark99 the most (Table
2-2). The predicted molecular weights are between 51.5 and 52.4kD, and
they have isoelectric points from 10.35 to 10.47. Although the overall nature
of the nucleocapsid protein is highly basic, there are also three acidic
regions with isoelectric points of 4.46, 3.94, and 3.58 (Fig. 2-2). In addition, it
is mainly a hydrophilic protein with a cluster of hydrophobic residues from
positions 270 to 284 (Fig. 2-2).
Coronavirus nucleocapsid proteins
Unlike BCV, TGEV, FECV, HCV-OC43 and HCV-229E, the IBV
nucleocapsid gene does not appear to have a large internal ORF. The
alignment of the amino acid sequences of the six strains of IBV shows that
there is a large region of absolute identity between residues 238 and 293
(Fig. 2-3) which corresponds to one of the basic regions. It also appears that
the protein is more conserved in the central region than at the ends.
We have characterized the nucleocapsid proteins of various
coronaviruses in order to locate highly conserved or highly variable regions.
A representative of each of the coronavirus antigenic groups is shown in the
alignment in Fig. 2-4 (Cruciere & Lapporte, 1988; Kamahora et al.t 1989;
Kapke & Brian, 1986; Lapps et al., 1987; Parker & Masters, 1990; Siddell,
1990; Vennema et al., 1991; Verbeek & Tijssen, 1991). The nucleocapsid
protein varies in size as well as composition from one coronavirus group to
15
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Fig. 2-2 Diagrammatic representation of the hydrophobic regions of the
nucleocapsid protein of IBV (upper panel) and the acidic and
basic regions of the protein (lower panel).
GRAY MASGKATGKTDAPAPVIKLGGPRPPKVGSSGNASWFQAIKAKKLNSPQPKFEGSGVPDNE 60
ARK9 9 K HP
HOLL52 T K L P
BEAUD A K T P
MASS41 K V NIP
KB8523 K PL
GRAY NFKTSQQHGYWRRQARFKPGKGRRKPVPDAWYFYYTGTGPAADLNWGDSQDGIVWVAAKG 120
ARK9 9 L V G
HOLL52 L L I*Q G S
BEAUD I P G T
MASS41 L S C G N G
KB852 3 L S G
GRAY ADVKSRSNQGTRDPDKFDQYPLRFSDGGPDGNFRWDFIPLNRGRSGRSTAASSAASSRPP 180
ARK9 9 H A
HOLL52 T I A
BEAUD T A A
MASS41 T F S A
KB8523 T K A
GRAY SREGSRGRRSGSEDDLIARAAKIIQDQQKKGSRITKAKADEMAHRRYCKRTIPPGYKVDQ 240
ARK9 9 D V
HOLL52 D A S
BEAUD D G N R
MASS41 V R N
KB8523 A A
GRAY VFGPRTKGKEGNFGDDKMNEEGIKDGRVTAMLNLVPSSHACLFGSRVTPKLQPDGLHLKF 300
ARK 9 9
HOLL52 R
BEAUD L R
MASS41
KB8523
GRAY EFTTWPRDDPQFDNYVKICDQCVDGVGTRPKDDEPKPKSRSSSRPATRTSSPAPRQQRIi 360
ARK 9 9 R P
HOLL52 S R PN Q
BEAUD C GN p
MASS41 R GN p
KB8523 S N G L p p
GRAY KKEKRPKKQDDEVDKALTSDEERNNAQLEFDDEPKVINWGDSALGENEL* 410
ARK 9 9 K N E
HOLD52 KS
BEAUD KL A Y A
MASS41 K C
KB8523 KT
Fig. 2-3 Amino acid comparison of the nucleocapsid proteins of six strains
of IBV. Spaces indicate positions for which the amino acids are
identical to those of the Gray strain.
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another. Group I viral genomes have the smallest nucleocapsid protein with
378 to 389 residues and group II have the largest with 449 to 455 residues.
There are also gaps interspersed throughout all the sequences in the
alignment. The amino acid residue numbers on the alignment in Fig. 2-3 do
not correspond to the numbers in Fig. 2-4, because the variation among the
sequences results in the insertion of gaps in specific sequences.
A plot of the similarity of all 17 protein sequences studied indicates
that there are two regions, corresponding to residues 129 to 138 and 147 to
153, with greater than average homology (Fig 2-5). In addition, the
sequence alignment shows several completely conserved residues, at
positions 91, 110, 129, 130, 133, 134, 135, 136, 146, 151, 152, 153, 180,
200, 300, 320, 329, 330, 331 and 360 (Fig 2-4). There is also variation
among the different species within the antigenic subgroups, such as is seen
between TGEV and HCV-229E, and with MHV compared with BCV, TCV
and HCV-OC43 (Fig. 2-4). This is reflected in the plot in Fig. 2-5 where, for
example, there is a very low similarity score between residues 265 to 300
due to a number of residues present only in one member of antigenic group
I, that is, HCV-229E. As with the IBV strains alone, there appears to be
overall less similarity at the ends of the protein than in the middle.
Phylogeny
The phylogenetic tree in Fig. 2-6 shows the relationship of these
viruses to each other based on their nucleocapsid genes and it clearly
indicates that the amino acid sequences are highly conserved within the
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Similarity plot of the nucleocapsid protein amino acid
sequence from 17 coronaviruses.
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antigenic groups. Overall sequence similarities classify IBV strains with the
other coronaviruses but the degree of divergence indicates they represent a
distinct group from the others. The other coronaviruses fall into two
branches, the first has fairly tight homology and includes MHV, BCV, TCV
and HCV-OC43, whereas the other appears to have diverged earlier with
HCV-229E being separated from TGEV and FIP. According to the
phylogenetic tree of IBV (Fig. 2-6) Gray and Ark99 are more closely related
to each other than to those strains of the Mass serotype. This suggests that
Gray and Ark99 may have diverged more recently from a common lineage.
Discussion
The nucleocapsid protein of coronaviruses is a highly immunogenic
protein that may be involved in stimulating cytotoxic T lymphocytes, and is
produced in large amounts relative to the other structural proteins in the cells
(Sneed et al., 1989; Boots et al., 1991; Cavanagh, 1983 ). Therefore, any
highly conserved regions may be worth considering as potential vaccine
components, especially if such determinants can be recognized by either B
or T cells. The nucleocapsid protein is variable among the different
coronaviruses, but is generally highly conserved among strains within a
species, such as IBV in chickens. Although little variation was found among
the IBV nucleocapsid proteins, according to the amino acid sequences,
there is more variation at the ends of the protein than in the middle. This also
appears to be true of the other members of the coronavirus family. Of the IBV
strains analyzed, Beaudette, Mass41, Holl52 and KB8523 all belong to the
same serotype, whereas Gray and Ark99 each belong to different serotypes.
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However, all appear to have originally derived from the Mass serotype with
Gray and Ark99 having evolved later. This correlates with the observation
that the Gray and Ark99 strains have both appeared more recently in the
U.S, and they are more closely related to each other than to the other strains
of IBV.
Serological studies have shown that coronaviruses fall into three
antigenic groups (Dea et al., 1990). Corresponding coronavirus groups can
also be distinguished in the phylogenetic tree in Fig. 2-6. BCV, TCV and
HCV-OC43 all appear to be genetically closely related when looking at the
nucleocapsid protein and clearly fall into the same antigenic group as MHV,
that is group II, however, MHV appears to have diverged earlier than the
other members of group II. Within group I there appears to be a wide
evolutionary distance separating HCV-229E from FIP and TGEV. The
nucleocapsid protein of IBV is in a group of its own, and considering the
amino acid sequence probably diverged earlier from the members of group
II and III.
Although the spike protein is highly variable (Cavanagh, 1991), it is
used as the basis for antigenic grouping by serological techniques (Dea et
al., 1990). The close correlation between antigenic grouping from serotyping
and from nucleocapsid sequences implies that the spike and nucleocapsid
proteins are evolving parallel to each other within distinct antigenic groups.
Thus, classification of coronaviruses may actually be determined on the
basis of either spike or nucleocapsid protein and presumably, this grouping
could also apply to the other coronavirus genes. If recombination is naturally
occurring as is expected (Cavanagh & Davis, 1988), it would seem to be
occurring within the antigenic groups, such as is seen with poliovirus (Agut
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et at., 1987). If this is the case, it would appear that the viability of the
progeny of coronaviruses depends on specific interactions of more than one
protein working in concert to maintain structural or replicative integrity of the
virus.
Regions of strong homology among these different nucleocapsid
proteins suggest a functional importance in viral replication that even over
time and evolution are very sensitive to change. It is interesting that the
acidic region nearest the amino terminal of IBV includes two regions which
are also very highly conserved among all the coronaviruses. The first region
has six out of ten amino acids completely conserved (129
FY(Y/F)(L/T)GTGP(H/A)(A/K) 136), and the two previous residues are at least
conserved in their hydrophobic nature; Leu-His in HCV-229E, Trp-His in
TGEV and FIP, and Trp-Tyr in all the other sequences. The second region
has four out of seven amino acids completely conserved (147
(D/E)G(V/I)(F/Y/V)WVA 153). However, the functional significance of these
residues is not known.
The nucleocapsid protein of coronaviruses is known to be associated
with the viral RNA and subgenomic RNAs and also to be an important part of
the replication machinery (Compton et a!., 1987). As yet, no regions of the
nucleocapsid protein have been assigned specific functions, but the basic
regions are most likely involved in nucleic acid recognition or binding.
However, there are no regions homologous to any known consensus RNA
binding proteins. Functional assignments to specific regions of the
nucleocapsid protein may provide the background for developing antiviral
reagents that target critical residues.
CHAPTER III
ANALYSIS OF A HYPERVARIABLE REGION IN THE 3' NON¬
CODING END OF THE INFECTIOUS BRONCHITIS VIRUS
GENOME
Introduction
Avian infectious bronchitis virus (IBV) is a highly contagious pathogen
of chickens with many strains varying widely in virulence, serotype, and
pathotype (Darbyshire et al, 1979; Hopkins, 1974). IBV was the first
coronavirus to be completely sequenced and is the prototype of the family
Coronaviridae (Boursnell et a/,1987). The IBV genome is 27.6kb in length
and consists of single-stranded RNA of positive polarity with a polyA tail
(Schochetman et al, 1977). Viral replication takes place under the control of
a viral RNA-dependent RNA polymerase produced by translation of the
genomic RNA. The polymerase presumably binds to the 3' end of the
genomic RNA to initiate transcription, resulting in the production of negative
sense RNA, either full length or subgenomic length, from which mRNAs can
be transcribed (Boursnell et al., 1987, Sethna et al., 1989).
Previous studies on infectious bronchitis virus (IBV) cDNA have
identified a T rich region of about 184 bases in the 3' non-coding terminus of
both the U.S. prototype strain (Beaudette) and a Japanese strain (KB8523),
that was not present in an antigenically closely related U.S. strain,
Massachusetts (Mass) 41 (Boursnell et al., 1985; Sutou et al., 1988). Since
the 3’ non-coding region of the IBV genome should be important in the
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recognition and/or binding of polymerase, we chose to examine the
sequences of this region of the genome. RNA from IBV strains Holl52,
ArkDPI (embryonating chicken egg passages) 11 and 75 and Mass41 were
screened by slot blot analysis in order to determine whether or not a U-rich
region could be detected using a probe corresponding to the nucleocapsid
gene of IBV. The cDNA sequences of the 3' non-coding regions of three
additional strains of IBV, Gray, Arkansas (Ark) 99 and Holland (Holl) 52,
were determined and compared to the sequences of the Beaudette, KB8523
and Mass41 strains.
Materials and Methods
Viral Preparation
The viral isolates used in this study were propagated at 37°C for 36-
48h following allantoic sac inoculation of 11-day old SPAFAS eggs. The
eggs were then refrigerated at 4°C for 5h, and allantoic fluid collected and
clarified by centrifugation at 16K x g for 20 min. Virus was precipitated
overnight with 8% polyethylene-glycol, 2.33% NaCI, and concentrated by
centrifugation at 16K x g for 20 min. Viral pellets were reconstituted in 1/50
vol 20mM Tris, 1mM EDTA, 100mM NaCI, pH7.4 and banded on a 30-50%
glycerol/potassium tartrate gradient for 2h at 100K x g.
After concentrating by ultracentrifugation at 100K x g for 1 h, virus
pellets were resuspended in 0.1M NaOAc, pH5.2, and the virions were
disrupted in 1 mg/ml proteinase K and 1% SDS at 37°C for 1h. The RNA
was extracted first with phenol and then with chloroform/isoamyl alcohol
followed by ethanol precipitation (Wang et al., 1988). Presence of IBV
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genomic RNA was confirmed by electrophoresis of a sample of the RNA on a
1% agarose gel while the remaining RNA was reprecipitated with ethanol.
Dot blot of four strains of IBV
A 40 base synthetic oligonucleotide was synthesized that was
complementary to the middle of the Ark99 U-rich region, and was labelled at
the 3' end using 32PdCTP and terminal deoxy transferase (Sambrook et
al., 1989). Genomic RNA from Mass41, Holl52, Arkansas DPI-11 and
ArkDPI-75 (passage 11 and passage 75 of a strain from the same serogroup
as ark99) was baked on to a nitrocellulose membrane at 80°C. The RNA
was applied in four-fold dilutions, starting with 1 jag, and dot blot hybridization
was performed at 42°C overnight in the presence of formamide (Sambrook
etal., 1989).
Hybridization studies with this Ark99 derived probe detected similar
sequences in genomic RNA from the Ark DPI11 and Ark DPI75 strains, but
not in Mass41 or Holl52 RNA, indicating, as expected, the presence of a
similar U rich sequence in Ark DPI (Fig. 3-1). However, this probe also did
not hybridize to Holl52, suggesting either that this strain did not contain this
region or that it was too dissimilar to be recognized by the Ark99-derived
probe. The cDNA sequences of two additional strains, Gray and Holl52,
were then examined and a comparable region was found in both.
Cloning of the Gray, Ark99 and Holl52 Strains
Purified RNA was pelleted and dried in a Savant vacuum drier. RNA
was resuspended in 7jil of deionized H2O (dH20) and denatured in 6mM
methyl mercuric hydroxide for 10 min at room temperature. First strand cDNA
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synthesis was carried out using 5 units of AMV reverse transcriptase (BMB,
Indianapolis, In) at 42°C for 2h in the presence of 14mM 2-mercaptoethanol
(2ME), 50mM Tris pH8.3, 50mM KCI, 8mM MgCl2, 0.8mM dNTP, 20|j.g/ml of
3’ end primer (5' GGATCCGCTCTAACTCTATACTAGC CTAT 3’) and 20
units of RNasin (Promega, Madison, Wi). Following phenol extraction and
ethanol precipitation of the RNA/cDNA hybrid, the RNA was eliminated by
exposure to highly alkaline conditions at 37°C for 3h. The cDNA was then
neutralized with HCI, concentrated by ethanol precipitation, and amplified
using the polymerase chain reaction (PCR).
The PCR reaction contained the same 3’ end primer as above, and a
primer from the upstream intergenic region (5' GAATTCCCGCGTGTACCTC
TCTAG TA 3') together with 4mM dNTP, 1 x Taq buffer (1.5mM MgCl2, 50mM
KCI,10mM Tris-HCI, pH8) and 0.5pl Taq polymerase (Perkin Elmer, Norwalk,
Ct.). The PCR was denaturated at 95°C for 3 min, then annealed at 50°C for
30s, and the sequence extended at 72°C for 1 min. Subsequent
denaturation steps were at 95°C for 1 min. A total of 30 cycles were used
with a final extension step of 3 min at 72°C. Resulting PCR products were
cloned into the pCRIOOO vector, utilizing the single T overhang at the
insertion site (Invitrogen, San Diego, Ca) and sequenced using the
Sequenase kit (USB, Cleveland, Ohio).
Computer Analysis
Resulting sequences were analyzed using the Genbank programs.
Nucleotide sequences were processed using the Seqed program and
comparisons of nucleotide sequences were made using Gap and Bestfit. IBV
sequences were aligned using Pileup with Gray set as the reference
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sequence. Output from the Pileup program was also displayed as a
similarity plot using Plotsimilarity, or as a phylogenetic tree using the
Macintosh program PAUP, version 3.0. Predicted secondary structures of the
3' non-coding region were derived from Fold and Squiggles.
Results
3' hypervariable region
The 3! non-coding regions of three strains of IBV were cloned and
sequenced in order to investigate the functional importance of this U-rich
sequence within the IBV group of coronaviruses and its extent in nature. A
similar U-rich region of 184 bases was found in the sequence of the Ark99
genome immediately downstream of the nucleocapsid gene where it had
been described in the Mass related strains.
A 40 base probe was synthesized that was complementary to the
middle of this Ark99 region. Hybridization studies with the Ark99 derived
probe detected simitar sequences in genomic RNA from the Ark99 and
ArkDPI strains, but not in Mass41 RNA, indicating, as expected, the
presence of a similar U rich sequence in ArkDPi-11 and ArkDPI-75 (Fig. 3-
1). However, this probe also did not hybridize to Holl52, suggesting either
that this strain did not contain this region or that it was too dissimilar to be
recognized by the Ark99-derived probe. After sequencing two additional
strains, Gray and Holl52, a comparable region was found in both strains.
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Fig. 3-1 RNA dot blot of 4 strains of IBV: Holl52, ArkDPI-11, ArkPI-75
and Mass41, with a cDNA probe from a portion of the T rich
region in the 3' non-coding region of Ark99. RNA samples were
applied to the membrane in four fold dilutions (from right to left).
Nucleotide sequences of the 3’ non-coding region of IBV
The nucleotide sequences of the 3' non-coding regions of the Ark99,
Gray and Holl52 strains of IBV were compared with the published
sequences for Mass41, Beaudette and a Japanese strain, KB8523
(Boursnell et al., 1985; Sutou eta/., 1988). Fig. 3-2 shows the alignment of
these sequences and demonstrates the high degree of similarity among the
strains.
However, the U rich region upstream of the 3' non-coding region, that
was absent from Mass41, was found in Holl52, as well as Gray and Ark99,
and was described as the 3' hypervariable region (HVR) because of the
extent of its variation among strains. This HVR ranged from 184 (Gray) to
196 (Holl52) nucleotides in length and the nucleotide sequence homologies
among the strains containing this sequence ranged from 53.2% to 92.8%,
with the Holl52 strain showing the greatest divergence (Table 3-1). The
greater variability of the Holl52 strain compared to the other strains in this
region immediately downstream of the nucleocapsid gene would explain
why this region was not detected with the Ark99 probe (Fig. 3- 1).
In comparison, the non-coding region downstream of this HVR was
highly conserved, ranging from 94.3% to 97.5% identity (Table 3-2). Fig. 3-3
shows a plot of the similarity of the nucleotide sequences of the 3' non¬
coding regions of all six strains of IBV. The HVR is clearly seen immediately
after the nucleocapsid gene and can be compared to the remaining 3' non¬
coding region which has very high similarity scores. This HVR could be
considered either an insertion or a deletion since it is not present in Mass41.
However, the higher U content in comparison to the rest of the IBV genome
suggests that it is of exogenous origin (Boursnell et al., 1985). The fact that it
Fig.3-2Nucleotidesequenccomparisonfth'n n-codingregionixstrai sIBV.Nucl ot desar numberedfromthstopc d nrnucleocapsigenewhi hiindi at dby* .T hypervariabler gionst rtsimmediat lyafterth pcodndontinuesb s213.Cons rv d basesinthisregionrunderlined.
Ark9 Gray Beaudette KB8523 Mass41 Holl52 Ark99
Gray
Beaudette KB8523 Mass41 Holl52 Ark99
Gray
Beaudette KB8523 Mass41 Holl52 Ark99
Gray
Beaudette KB8523 Mass41 Holl52 Ark99
Gray Beaudette KB8523 Mass41 Holl52 Ark99
Gray Beaudette KB8523 Mass41 Holl52
GGATTCAGCTTTAGGTGAGAA C TT.T AGATTCTGCTTTAGG GAGAA G ACT GGATGCAGCTCTAGGAG AAT A CTTT.T TGACTCAGCACTTGG G AAATGAACTTTG.T GGATTCAGCTCTAGGAG AAT C TTG GGATTCAGCACTTGGAG AAT AG TAA GCT GATTTCCAACT A * ATTATTTCTGTGCTTTC ATCAA CA ACAGGCAT GATTGT ACTATTTTTGTGCTTTCC ATCA TTACAG A GATTG A ACTATTTCTGTG T CCTATC A TA ACAG A GATTG TTTGTTTTTGTAGAT C CAC A A ATTGG.AA GATTG G TA
100
CATAATGGACCTGCTGCATTCTTTG CATTTG TA C CATAATGGACCTGCTGCATTTTTTG CATTTG A CC CATAATGGACCTG TG..TTTCCTGG ACATTTG TAAAC CATAATGGACTTGCTGCACTT TCTGATTC TG CATCATGGACGTGCGTATGCTGTT T CCCTAC AGT CT G
200
GTGCAATATTTAA TTTCTTTT GTTG TTT GCT G TG A TG C GTGCAATATTTAAGCTTCTTT GTTGC TT GCTTG TG G T C GTTCAATACTTAAG TTCTTT G TGC TTTTGCTTA TGTA TG GC GTGCAGTATCTTAGTTGGTTTAA TATC TGT GCAG TTGTG T T C
ATTATTTTTTGC AT G A TGTGCTTTTTA TATTG GA TGTGCTTTTTA TATTG CA TGTGCTTTTTA TGTTGTGA TGTGCTTATTG T TTATGC TGTTGTTCTTGTTC TACTC CTATCGCCAGGGA AT T T CTATCGCCAGGGA AT T T GTATCGCCAGGGA AT T T CTATCGCCAGGGA AT T T CTATCGCCAGGGA AT T T CTATCGCCAGGGAAAT TCT TAGTTTAGAGTAG A A TAGTTTAGAGTAG A A TAGTTTAGAGTAG A A TAGTTTAGAGTAG A A TAGTTTAGAGTAG A A TAGTTTAGAGTAG A A TTTAAGTTAAG T TTTAAGTTAAGTTTAATTGG TTTAAGTTAAG TTGG TTTAAGTTAAGTT TTGG TTTAAGTTAAG T GG TTTAAGTTAAGTTTAATTGG
TGGTTTATTACA GA GA TTCTCATTAGT GTTT AT TTCTC...AGT TGCTTT T TTCTCATTAGT GCTT AT TGCTTTATTCT TGT ATA TACTGTTCTCT TTCT A AATCTGTCTACTT GTAGCC AATCTGTCTACTT GTAGCC AATCTGTCTACTT GTA C AATCTGTCTACTTAGTA C AATTTGTCTACTT GTAGCC AATCTGTCTACTT GTA C GATGCCAGTGCCGA G CAC GATGCCAGTGCCAG G CAC GATGCCAGTGCCGG G CAC GATGCCAGTGCCGG G CAC GATGCCAGTGCCGG G CAC GAAGCCAGTGCCGGGGCC C CTAAGTATAGTTA A T CTAAGTATAGTTA A T CTAAGTATAGTTA A T CTAAGTATAGTTA A T CTATGTATAGTTA AA T CTAAGTATAGTTA A T
TTGTATGTATT GT G AC CGTAGAAGTTCAA T AG TGTAGAAGTTCAA T AG CGTAGAAATTCAA T G CGTAGAAGTT...TATTGAA ....AAAATTCAATAGTAAG TTTAGAGTATCAA ...AG TGGAAACGAACGGTAGA CC TGGAAACGAACG T G CC TGGAAACGAACC TAG CC TGGAAATGAACG TAG CCC TGGAAACGAACG TAG CC TGGAAACGAACG TAG CC GCGGAGTACGAT AG GTA GCGGAGTACGAT AG GTA GCGGAGTACGAT AGGGTA GCGGAGTACGATCGA GGTA GCGGAGTACGAC AG GTA GCGGAGTACGAT AG GTA TAGGCTAGTATAGA TTAGA TAGGCTAGTATAGA TTAGA TAGGCTAGTATAGA T A TAGGCTAGTATAGA TTAGA TAGGCTAGTATAGA TTA A TAGGCTAGTATAGAGTTAGA
CTCGTATGTTCTATA TATG AGTTAAGGGAGATAGGCAT AGTTAAGGAAGATAGGCATG AGTTAAGGAAGATAGGCATG AGTTAAGGAAG TAGGCATG AGTTAAGGAAGATAGGCATG AATCAAGGAAG TAGGCATG TTAGATTTTAA TTAG TTAGATTTTAA TAG A TTAGATTTTAA TAG TA TTAGATTTTAA TAG A TTAGATTTTAA TAGTTTA TTAGATTTTAA TAG A CAGCACTAGGA GC CACTA CAGCACCAGGAC C ATTA CAGCACTAGGAC C ATTA CAGCACTAGGACGCCCACTA CAGCACTAGGA GCCCATTA CAGCACTAGGA GCCCACTA 563 GC. GC. GC. GCA GC. GC.
TTTTCTGTAGT G A TAG
300
TAGCTTGATTACCTACATGT TAGCTT.AGCACCTACATGT TAGCTTGATTACCTACATGT TAGCTTGATTACCTACATG TAGCTTGATTACCTACATGT TAGTTTGATTACCTACATGT
400
ATTTTTAGTTT G AAGT ATTTTTAGTTT GTTTAAGT ATTTTTAGTTT G AAGT ATTTTTAGTTT GTTTAAGT ATTTTTAGTTT G A ATTTTTAGTTT G TAAGT
500
GGGGAAGAGCTAAATTTT GGGGAAGAGCTAAATTTT GGGGAAGAGCTAAATTTT GGGCAAGAGCTAAATTTTA GGGGAAGAGCTAAATTTT GAGGAAGAGCTAAATTTT
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Fig. 3-3 Similarity plot of the 3’ non-coding region of six strains of IBV.
This plot starts from the end of the nucleocapsid gene and
covers the 3* HVR and conserved 3' end.
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Table 3-1. Percent homologies of the nucleic acid sequences of the 3'
HVR in 5 strains of IBV.
Ark99 Gray Beau Holl52 KB8523
Ark99 100 91.8 91.8 53.2 68.6
Gray 100 92.8 57.9 67.6
Beau 100 57.1 66.7
Holl52 100 60.0
KB8523 100
Table 3-2. Percent homologies of the 3' non-coding region downstream of
the HVR of 6 strains of IBV.
Ark99 Gray Beau Hol(52 KB8523 Mass41
Ark99 100 97.2 97.5 94.7 97.2 96.3
Gray 100 97.8 94.3 96.8 96.6
Beau 100 94.7 97.2 97.5
Holl52 100 95.3 94.3
KB8523 100 94.7
Mass41 100
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has at least 53.2% identity among various strains suggests a common
ancestry for this sequence.
If the IBV genome acquired the HVR as exogenous RNA, this region
could be a site for recombination. Sequences upstream and downstream of
the HVR were analyzed to identify any distinctive patterns which would
suggest that this region is of functional significance, such as being involved
in recombination. Not only are the sequences flanking the 3' HVR highly
conserved, the 5’ flanking sequence also resembles the cutting site (5' TTAA
3') of retrovirus DNA and transposons Tn10 and Tn3 (Shoemaker et al.,
1980). It was of special interest that a unique pattern, that may be of
functional importance, was observed in the oligonucleotides flanking the
HVR. Several nucleotides downstream of this 3' HVR were mirrored in the
sequences upstream. That is, the same sequences were seen in reverse
orientation on either side of the 3’ HVR. An example can be seen in the
Gray strain where the sequence TGAGAATG appears 5’ of the HVR and the
sequence GTAAGAGT is in the 3’ flanking sequence (Table 3-3). The
function of these mirrored sequences is unknown; however, they may be
important in preventing folding of the RNA in this region, as mirrored
sequences should prevent complementary base pairing.
The variability of this HVR as compared to the conservation of the
remaining 3’ non-coding sequences suggests that the primary sequence
itself may not be as functionally important as its influence on the secondary
structure of the 3’ end of the genome. The impact of the 3' HVR on RNA
secondary structure was examined by determining the predicted secondary
structure of the 3' non-coding region of each of these six IBV strains. Putative
secondary structures, which can be seen in Fig. 3-4, show that the 3' non-
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Table 3-3.
ARK 9 9
GRAY
BEAUD
KB8523
MASS41
HOLL52
Mirrored sequences flanking the 3' hypervariable region. |*|
indicates the position of the insert.
TGAGAATGAACTTTGAA | * | AGTTCAATAGTAAGAGT
TGAGAATGAACTCTGAGG | * | AGTTCAATAGTAAGAGT
AGAGAATGAACTTTGAG | * | AATTCAATAGTAAGAGT T
GAAAATGAACTTTGAT|*|AGTTTATTGAAAGTTAAG
GAGAATGAACTTTGAGT|*|AAAATTCAATAGTAAGAGT
GGAGAGAATGAGTTGTAA| * |GTATCAATAAGAATCAAGG
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Fig. 3-5 Phylogenetic tree of six strains of IBV based on the sequences
of their 3' non-coding regions.
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coding region of the Mass41 strain, without the 3' HVR, has fewer branches
with hairpin loops than the other strains. Although this program automatically
aligns the ends of the input sequence and the rest of the genome is ignored,
it still gives an idea of how the secondary structure may be affected by the
presence of the 3' HVR.
Phylogeny
The sequence relationships of the 3’ non-coding regions were
examined with a phylogenetic tree (Fig. 3-5). The Holl52 and KB8523
strains were shown to be more distantly related to the other strains. The 3'
non-coding sequences of Mass41, in spite of the absence of the HVR,
appeared to be closely related to the Beaudette, and to a lesser extent to the
Gray and Ark99 strains. The program used to determine this tree counts the
absence of this whole HVR in Mass41 as the result of one recombination
event, so only the remainder of the 3' non-coding region of the Mass41
strain was considered for the construction of the phylogenetic tree.
Discussion
There is considerable evidence for recombination in the
Coronaviridae family, presumably resulting from polymerase pausing,
detachment and homologous or heterologous reattachment during RNA
synthesis. (Banner et al., 1990; Baric et al., 1990; Keck et al., 1988a; Keck et
a/., 1988b; Kusters et al., 1990, Makino et al., 1986; van der Most et al.,
1992; Lai, 1992). Recombination may also be responsible for the
emergence of the nonenteropathogenic porcine respiratory coronavirus
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(PRCV). PRCV is thought to have been derived from transmissible
gastroenteritis virus (TGEV) by a deletion of a region of approximately 240
amino acids in the S protein. This deletion has resulted in the absence of
two antigenic sites in PRCV isolates and is the basis for their differentiation
from the enteropathogenic TGEV (Sanchez et al., 1992).
The location of the IBV 3’ HVR is conserved at a position immediately
downstream from the stop codon of the nucleocapsid gene. Unlike the case
with the porcine coronaviruses, there is no evidence as yet to show that this
HVR has any effect on virulence or pathogenesis. However the sequences
flanking the 3' end of the HVR are similar to the tetrameric (TTCC) or
heptameric (AGTTTCC) repeats found within the regions deleted from the
PRCVs.
There are no detectable protein products from the 3f HVR and no
methionines with a preceding putative consensus ribosomal binding site.
Since it is completely absent in the Mass41 strain, it would appear that it is
not an absolute requirement for viral replication, at least for Mass41. Any
specific function of this HVR apparently does not dictate that the sequences
be highly conserved but its function may depend on the secondary structure
of the RNA. The variability of this HVR as compared to the conservation of
the remaining 3' non-coding region suggests that the primary sequence
itself may not be as functionally important as its influence on the secondary
structure of the 3' end of the genome. It is possible that the presence of the
HVR may increase the complexity of the secondary structure of the RNA
which could in turn affect its association with replication machinery, such as
RNA binding proteins.
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CHAPTER IV
EXPRESSION OF THE NUCLEOCAPSID GENE OF IBV AS A
HISTIDINE FUSION PROTEIN IN E. COLI
Introduction
The nucleocapsid protein of IBV is one of the three major structural
proteins of the virion. This protein is internally localized, makes up
approximately 40% of the total viral protein, and is thought to be involved in
the induction of protective immunity (Cavanagh, 1983; Boots et al., 1992).
Such protection may be induced by generating cytotoxic T cells (Lutticken et
al., 1988), and also by generating T helper cell responses that augment the
activity of B cells in the production of viral-neutralising antibody specific for
the spike protein (Boots et al., 1992). Therefore, the nucleocapsid protein is
a potential target for vaccine development, especially as it is much more
highly conserved than the spike protein, which is responsible for the
induction of neutralising antibodies.
The nucleocapsid protein of coronaviruses is closely associated with
the RNA genome, has been shown to be involved in transcription of MHV,
and may be involved in translation (Compton et al., 1987). Further
information on this RNA-protein interaction may help with the development
of either a vaccine or anti-viral agents specific for all serotypes of IBV.
With this goal in mind, the nucleocapsid gene of IBV was sub-cloned
into the pQE8 expression vector (Qiagen, Chatsworth, CA) and
subsequently produced in E. Coli with a tag of six histidine (6 x His) residues
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(Fig. 4-1). This Qiaexpress system allows for the expression of recombinant
proteins in E. coli which may then be purified by a single, rapid
chromatography step based on the affinity of the 6 x His tag for a Ni2+-NTA
column (Fig. 4-2a). The recombinant protein may then be easily eluted by
competition with imidazole which binds to the Ni-NTA and displaces the
histidine tagged protein (Fig. 4-2b).
Materials and Methods
PCR amplification of the nucleocapsid gene
The nucleocapsid gene of the Gray strain of IBV was cloned and
sequenced (Chapter II). Specific primers spanning the nucleocapsid gene
were chosen to perform PCR amplification of the nucleocapsid gene of IBV,
in order to subclone it into the correct open reading frame (orf) of the pQE8
vector. PCR was performed with the upstream primer 5’ TCTGGATCCATGG
CAAGCGGTAAGGC 3' and the downstream primer 5’ GTTGGATCCGAGTT
CATTCTCACCTAAAGC 3\ in the presence of 4mM dNTP, 1x Taq buffer
(1.5mM MgCl2, 50mM KCI,10mM Tris-HCI, pH8) and 0.5jil Taq polymerase
(Perkin Elmer, Norwalk, Ct.). The PCR was performed with a primary
denaturation step at 95°C for 3 min, annealing at 50°C for 30s, extension at
72°C for 1 min, and subsequent denaturation steps at 95°C for 1 min. A total
of 30 cycles were used with a final extension step of 3 min at 72°C.
The PCR primers were designed with BamH1 recognition sequences
at their 5' ends. This enabled 5pg of the resulting PCR product to be
digested with 2units of BamH1 (Promega corporation, Madison, Wl) in buffer
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R1 R2
P/O
6xHis Protein - X ■Ni
Fig. 4-1 Diagrammatic representation of the nucleocapsid gene in the
QIAexpress system. The nucleocapsid gene was subcloned
into the BamH1 site of pQE8. P/O represents the promotor and
two lac operators.
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Fig. 4-2 Model for the binding of neighboring 6 x His residues to Ni-
NTA resin. NTA associates with 4 of the 6 Ni2+ spheres leaving
2 to bind to the histidine residues (above), and structures of
imidazole and histidine (below).
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C (50mM NaCI, 10mM Tris-HCI, pH7.9, 10mM MgCl2, 1mM DTT) at 37°C for
2h. Following the addition of a 1/10 volume 10X loading buffer, the reaction
solutions were loaded onto a 0.8% low melting point agarose gel and
electrophoresed at 60V to purify the digested nucleocapsid gene PCR
product. The nucleocapsid DNA band was excised and the agarose melted
at 56°C in 10mM Tris-HCI, pH 7.6, 1mM EDTA, pH 8.0 (TE). Following
phenol extraction, the DNA was precipitated with 0.3M NaOAc, pH5.2 and
two volumes of ethanol at -20°C for 2h.
Preparation of cells for electroporation
M15/pRep4 cells were grown overnight at 37°C with shaking in 2ml
Luria Bertani (LB) media (10g/L Bacto tryptone, 5g/L Bacto yeast extract,
10g/L NaCI, pH 7) supplemented with 25[jig/ml kanamycin. 200ml LB media
supplemented with 25^ig/ml kanamycin were then inoculated with this 2ml
culture and shaken at 37°C for 3h. The cells were spun at 6K x g for 5min
and the pellet was resuspended in 200ml cold dH20. This step was
repeated twice with the cells being resuspended in 100ml cold dH20 then
15ml 10% glycerol in dH20. Following a final spin of 20min at 10K x g, the
cells were resuspended in 400jaI 10% glycerol in dH20, and 40ptl were
aliquoted into pre-chilled microfuge tubes. These cells were then stored at
-70°C until they were needed.
Cloning into the pQE8 vector
Two hundred ng of pQE8 were digested with BamH1 and the
fragments gel purified as described above. A ligation reaction was set up
overnight at 11°C with 10ng nucleocapsid DNA and 5ng pQE8 DNA, in the
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presence of 1 unit T4 DNA ligase (Promega, Madison, Wl), 300mM Tris,
pH7.8, 100mM MgCl2, 100mM DTT and 10mM ATP. These ligation products
were then used to transform M15/pRep4 cells. Cells were thawed on ice and
1 pi of the ligation product was added to 40pl cell aliquots. The cells were
subjected to electroporation at 12.5kV/cm for 5msecs (BTX, San Diego, CA).
Following the addition of 1.5ml LB the cells were grown at 37°C for 1h with
shaking before spreading 50pl onto plates containing 25pg/ml kanamycin
and 100pg/ml ampicillin. Plates were incubated at 37°C overnight and
recombinant colonies selected for screening the following morning.
Recombinant colonies were streaked onto LB plates containing
25pg/ml kanamycin and lOOpg/ml ampicillin, and incubated at 37°C
overnight. The bacteria were collected using blunt toothpicks and
resuspended in 80pl STE buffer (100mM NaCI, 20mM Tris, pH7.5 and
10mM EDTA). DNA was extracted after mixing with 80pl phenol: chloroform:
isoamyl (25:24:1) and 0.25pg RNase was added to the DNA fraction (top
layer). One pi of DNA was examined on a 1% agarose gel and the
remainder was precipitated with 0.3M NaOAc, pH5.2, and 2 volumes of
ethanol in a dry ice-ethanol bath for 5min. DNA was collected following
microcentrifugation at 12,000g for 10min.
BamH1 digestion was performed as described above and clones that
appeared to have an insert were then sequenced using Sequenase (USB,
Cleveland, Ohio) in order to confirm that the correct sequence was inserted
into the vector and that the open reading frame was intact. Positive clones
were screened for nucleocapsid protein production.
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Rapid screening of small scale expression cultures
Single colonies from positive transformants were grown at 37°C with
shaking in individual 10ml cultures (LB, 100^g/ml ampicillin, 25^g/ml
kanamycin). When the OD600 reached 0.7-0.9, IPTG was added to a final
concentration of 2mM and cultivation continued for another 5h. Cells were
collected from 1ml of the culture by centrifugation for 1.5min (Eppendorf
microcentrifuge) and boiled for 7min in 200fxl sample buffer (3% 2-ME, 3%
SDS, and 0.5% bromophenol blue). After cooling, 10^1 were applied to a
12.5% SDS polyacrylamide gel (Sambrook eta/., 1989) and subjected to
electrophoresis at 200v (Bio-Rad mini PAGE, Bio-Rad, Richmond, CA) until
the bromophenol blue dye front reached the bottom of the gel. The proteins
were then visualized by staining with Coomassie blue (Sambrook et al.,
1989).
Determination of expressed recombinant protein solubility and
compartmentalization
Positive clones were chosen to express recombinant nucleocapsid
protein. In order to choose the best purification protocol using non¬
denaturing buffers, the localization of the recombinant protein was
determined. Cells were grown and induced in 100ml cultures of LB media as
described above along with a control culture of untransformed M15/pRep4
cells. Just before induction, a 1ml sample was taken from each of the
cultures for use as an uninduced control on SDS-PAGE. These cells were
resuspended in 50^1 SDS-PAGE buffer and kept on ice. Before harvesting
the remaining cells, a second sample of 0.5ml was taken as the induced
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control, the cells were collected as before, resuspended in 100pl SDS-
PAGE buffer and kept on ice.
The induced cultures were divided into 2 aliquots, and the cells
harvested by centrifugation at 4000 x g for 10min. The supernatants were
discarded and one cell pellet was resuspended in 5ml sonication buffer
(50mM NaH2P04, pH8, 300mM NaCI), supplemented with 1 mg/ml
lysozyme, and kept on ice for 5 min before processing for cytosolic
localization. The other cell pellet was resuspended in 10ml of 30mM
TrisHCI, pH8, 20% sucrose, in order to check for periplasmic localization.
The cells examined for cytosolic localization were frozen in a dry-ice
ethanol bath and thawed in cold water before sonicating for 3min. Following
centrifugation at 10,000 x g for 20min, the supernatant was decanted and
saved on ice. This fraction contained the soluble proteins. Meanwhile, the
cell pellet was resuspended in sonication buffer to suspend the insoluble
fraction.
The samples examined for periplasmic localization were adjusted to
1mM EDTA and incubated at room temperature for 10min on a rocking
platform. Following centrifugation at 8000 x g for 10min, the supernatant was
removed and the cell pellet resuspended in 10ml ice cold 5mM MgSC>4.
After shaking for 10min in an ice-water bath, the cells were centrifuged as
above and the supernatant, or osmotic shock fluid, decanted and saved.
These three fractions of each of the two samples and the cell control
were then analyzed by SDS-PAGE. Five pi of 2 x SDS-PAGE sample buffer
was added to 5pl of the crude extracts of insoluble and soluble protein, and
10pl of SDS-PAGE sample buffer were added to 10pl of the osmotic shock
fluid. These samples were boiled, along with the uninduced and induced
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cell samples, for 5min. After microcentrifugation for 1 min, 20pl of each of the
samples were loaded onto an SDS-PAGE gel as described above.
Extraction and purification of the recombinant nucleocapsid
protein under non-denaturing conditions
A positive clone was grown and induced in a 1L culture as described
above. The cells were harvested by centrifugation at 4,000 x g for 20min,
then resuspended in 6ml sonication buffer supplemented with 1 mg/ml
lysozyme. The sample was incubated for 5min on ice, then 0.66ml 3M NaCI
was added and the sample incubated on ice for another 5min. The ceils
were sonicated for 5min on ice, centrifuged at 10,000 x g for 30min and the
supernatant collected.
The supernatant was loaded onto a large (8ml) Ni2+-NTA column
(Qiagen, Chatsworth, CA) pre-equilibrated with sonication buffer. The
column was washed with 10 volumes of sonication buffer supplemented with
20mM imidazole to reduce the background of cellular proteins. The
recombinant nucleocapsid protein was eluted with sonication buffer, pH 7,
supplemented with 250mM imidazole. Two ml fractions from the column
were collected using a fraction collector connected to a UV monitor (Biorad)
to determine when the protein was eluted. Ten pi of each of these fractions
was then analyzed by SDS-PAGE and a duplicate gel was transferred to
nitrocellulose membrane for western blotting analysis with IBV polyclonal
antisera. Fractions containing the recombinant protein were concentrated
using an Amicon centriprep 10 concentrator (Amicon, Beverly, MA) and
duplicate samples were run on a SDS-PAGE for staining with Coomassie or
transferred to nitrocellulose for western blotting with anti-IBV antisera.
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Results
Protein expression
In order to study the interaction of IBV RNA with the nucleocapsid
protein, the gene was sub-cloned into the pQE8 expression vector which
can be used for the expression of large amounts of the purified protein. Out
of a number of recombinant colonies screened, two were chosen that upon
sequencing showed the nucleocapsid gene to be inserted into the vector
with the ORF intact. These two clones, #3 and #68, were then analyzed in
small scale expression cultures to confirm that the recombinant protein was
synthesized upon induction with IPTG.
Duplicate samples of the small scale expression cultures from the two
clones and a cell control were analyzed by SDS-PAGE (Fig. 4-3). The
recombinant nucleocapsid protein is indicated by an arrow and corresponds
to the expected MW of the nucleocapsid protein, which is approximately
50kD. Even against the background of cellular proteins, this band could be
clearly seen in the induced cultures of clones #3 and #68, and is absent
from the cell controls. Clone #68 expressed the nucleocapsid protein more
efficiently than clone #3.
Solubility and localization of the recombinant protein.
Before expressing the nucleocapsid protein on a preparative scale
under non-denaturing conditions, the solubility and compartmentalization of
the recombinant protein needed to be determined. Three fractions of each of
the samples representing the insoluble protein matter, the cytoplasmic
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Fig. 4-3 Crude protein preparations of uninduced and induced cultures
of clones #3 and #68 and a cell control. The recombinant
protein is indicated by an arrow and is present in the induced
lanes of #3 and #68.
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-34
-26
Fig. 4-4 a) SDS-PAGE of cellular fractions collected to determine the
cellular localization and solubility of the recombinant protein.
Recombinant protein is indicated by an arrow and is present in
the cytosolic and insoluble fractions of #68. b) represents a
parallel western blot of (a) showing the nucleocapsid protein in
all lanes of the two clones except for the periplasmic fraction
lane. Recombinant protein is indicated by an arrow.
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protein fraction and the periplasmic protein fraction were collected. Samples
of these protein fractions, along with uninduced and induced samples, were
run on an SDS-PAGE and also transferred to nitrocellulose for western blot
analysis with polyclonal anti-IBV antibody. The recombinant protein is
indicated by an arrow and was present in both the insoluble and cytoplasmic
fractions, but not in the periplasmic fraction (Fig. 4-4a). The fact that the
protein was present in the cytoplasmic fraction indicated that it was soluble,
and its presence in the insoluble fraction was probably due to incomplete
lysis of the cells. For future expression cultures, the cells were sonicated for
5min instead of 3min, and most of the protein was then seen in the
cytoplasmic fraction.
Although there was some background non-specific protein
recognition, the western blot of these fractions clearly showed the
nucleocapsid protein in the cytoplasmic and insoluble fractions of clones #3
and #68, as well as in the induced samples of #68 (Fig. 4-4b). There was no
binding of anti-IBV antibody to proteins at the corresponding position in the
cell control lanes.
Purification of the recombinant protein
Having determined the localization of the recombinant protein, large
quantities of the protein were produced for purification by Ni-NTA affinity
chromatography. UV monitoring of the fractions collected from the column
showed large amounts of protein released from the column very soon after
the addition of 250mM imidazole. The gel of these fractions (Fig. 4-5a)
shows the nucleocapsid protein was released in eluate fractions 2 through
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Fig. 4-5 Elution fractions collected following the addition of 250mM
Imidazole to the Ni-NTA column: a) SDS-PAGE, b) Western
blot. Recombinant protein is indicated by an arrow, and is seen
in fractions 2 to 6 on both the gel and the western blot.
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Fig. 4-6 Confirmation that purified and concentrated recombinant
protein was the nucleocapsid protein by SDS-PAGE (left) and
Western blot (right). Nucleocapsid protein bands are indicated
by an arrow.
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6, and the presence and localization of the nucleocapsid protein was
confirmed by the western blot seen in Fig. 4-5b.
For future experiments, the nucleocapsid protein was concentrated
with a centriprep 10 concentrator (Amicon). To ensure the protein was not
lost during the concentration step, a fraction was analyzed by SDS-PAGE
(Fig. 4-6a), and the presence of the nucleocapsid protein confirmed by
western blot analysis (Fig. 4-6b). The recombinant nucleocapsid band also
co-migrated with the band presumed to be the nucleocapsid protein in a
sample of whole IBV. In addition to the nucleocapsid protein, there were also
several smaller bands seen on the gel in the recombinant protein lane, but
the fact that these were recognized by the anti-IBV antisera suggested that
they were simply proteins produced by premature termination of translation.
Since the 6 x His tag is at the amino terminal of the protein, any such
premature termination products would be absorbed onto the column and
thus co-purify with the full length nucleocapsid protein.
In order to determine the efficiency and specificity of the Ni-NTA
affinity chromatography, another preparative scale expression was
performed. Fractions corresponding to the flow-through, (the proteins not
absorbed onto the column matrix) the washes, and the eluate following
addition of 250mM imidazole, were collected and analyzed by SDS-PAGE
(Fig. 4-7). The nucleocapsid protein is indicated by an arrow, and this band
was clearly seen in the induced #68 before chromatography, and also in the
eluate and in the #68 control (the sample already checked by western
blotting in Fig. 4-6b). The lane corresponding to the flow-through contained
large amounts of cellular protein, but not nucleocapsid protein, passing
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Fig. 4-7 SDS-PAGE of fractions collected from the Ni-NTA column
during purification of the nucleocapsid protein. Recombinant
protein is indicated by an arrow.
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immediately through the column. Although some cell proteins did remain in
the column, these were rapidly removed with the addition of low amounts of
imidazole in the wash buffer, as these proteins had a very low affinity for the
column. The later wash fractions were very clean, suggesting that any
proteins remaining in the column had a high affinity for the Nickel by virtue of
their 6 x his tag. This ensured that the eluate upon addition of high levels of
imidazole was reasonably pure.
Discussion
Large quantities of purified protein were needed to analyse the
interaction of the IBV nucleocapsid protein with RNA. For this purpose, the
nucleocapsid gene was sub-cloned into the pQE8 vector, expressed in E.
coli, and purified on a Ni-NTA column by virtue of a six residue histidine tag
at the amino terminus. Analysis of the purified protein by western blot shows
the sample to be contaminated only with smaller proteins presumed to be a
result of premature termination of translation. As these proteins correspond
to portions of the nucleocapsid protein, we presumed they would not
interfere with our future experiments. However, these protein products could
be eliminated by the expression of the protein in the pQE12 vector which
contains the histidine tag at the carboxy terminal so that only full length
protein products would be absorbed onto the column. The problem with
placing a histidine tag at the carboxy terminal of the protein is that it is more
likely to affect the folding of the protein and also its solubility in E. coli (The
QIAexpressionist, QIAgen, 1992). Therefore, a histidine tag at the amino
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terminal, which is recommended for purification of the protein under non¬
denaturing conditions, remains the method of choice for these experiments.
Because in nature the nucleocapsid protein of IBV is phosphorylated
(Siddel et al., 1981; Stohlman & Lai, 1979; Sturman eta/., 1980), future
experiments should include the determination of the phosphorlyation status
of the nucleocapsid protein in E. coli.. In the infected cell it is thought that the
nucleocapsid protein is phosphorylated by a virion-associated protein
kinase (Siddell et al., 1981a), and although the effect of this phosphorylation
on replication is unknown, it could affect the in vitro interaction between N
and E1 in the human coronavirus JHM (Sturman et al., 1980).
Although E. coii contains protein kinases, these probably do not
specifically phosphorylate foreign proteins. In which case, if the
nucleocapsid protein produced in M15/pREP4 cells is phosphorylated, it is
probably due to non-specific phosphorylation which may not be the same as
its phosphorylation in eukaryotic cells. However, recombinant-derived
nucleocapsid protein produced in a bacterial expression system has been
shown to be capable of inducing a cellular immune response to IBV, and is
recognized by anti-IBV antisera, suggesting that the protein has some
biological activity regardless of its phosphorylation (Boots et al., 1992). This
recombinant protein was then used to investigate the association of the IBV
nucleocapsid protein with RNA from the 3' end of the IBV genome.
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CHAPTER V
BINDING OF THE IBV NUCLEOCAPSID PROTEIN TO RNA
SEQUENCES SPECIFIC FOR THE 3' END OF THE IBV GENOME
Introduction
The IBV nucleocapsid protein is a highly basic, phosphorylated
protein of 409 amino acids and a relative molecular weight of approximately
50kD. A 140kD trimer of the nucleocapsid protein of MHV has been found in
non-reduced preparations of purified virions suggesting the presence of
disulphide linked multimers (Robbins et al., 1986). The nucleocapsid protein
of coronaviruses is closely associated with the RNA genome, has been
shown to be involved in transcription of murine hepatitis virus (MHV)
(Nakanaga et al., 1986) and may also be involved in translation (Compton et
al., 1987). Although coronaviruses are the only positive sense RNA viruses
known to have a helical nucleocapsid, several negative sense RNA viruses
have helical nucleocapsids that are important in regulating viral transcription
(Arnheiter et al., 1985; Banerjee, 1987).
Since the IBV genome is infective and codes for polymerase
function, release of the nucleocapsid into the cytoplasm of the infected cell is
followed by the translation of the polymerase genes from genomic RNA
(Stern & Kennedy, 1980a; Stern & Kennedy, 1980b). Two overlapping
reading frames at the 5' end of the genome are capable of coding for two
large polyproteins which are presumably involved in polymerase function
(Boursnell et al., 1987; Brierley et al., 1987). Translation of the first ORF (F1),
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at the 5' end, results in a putative protein of 441 residues. The second
putative polyprotein encoded by this gene complex would be a fusion
protein with the amino terminus being in common with the 441 residue
polyprotein from the F1 ORF. The unique carboxyl 300 residues are
transcribed from the F2 ORF in a -1 frame relative to the F1 (Brierley et al.,
1987). The F2 is translated as a result of the ribosomes slipping back one
nucleotide before the F1 stop codon and thus reading through this stop
codon and continuing into the F2 ORF (Brierley et al., 1987; Brierley et al.,
1989).
A distinguishing characteristic of coronaviruses is their transcription
strategy. Following primary translation, polymerase enzymes direct the
transcription of a negative-stranded RNA template used for the transcription
of the five subgenomic mRNAs (Baric et al., 1983; Lai et al., 1982b; Lai et al.,
1987). The subgenomic mRNAs are used as mRNAs for translation of the
remaining proteins, in particular, the structural proteins required for virion
assembly. It has also been demonstrated that subgenomic minus-strand
RNA molecules are present in cells infected with the coronaviruses TGEV
and MHV (Sethna et al., 1989; Sawicki & Sawicki, 1990). These
subgenomic minus-strands may also serve as template for the
corresponding subgenomic mRNAs.
The unique mechanism for producing subgenomic RNAs used as
messages for protein synthesis is thought to be mediated through the
presence of the leader sequences found upstream of each message (Baric
et al., 1987; Baric et al., 1985; Makino et al., 1986b). The leader sequence is
found only in the 5’ non-coding terminus of the genome (Brown et al., 1984;
Boursnell et al., 1989). Excess copies of free leader fragments are made
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during replication, and subgenomic RNA species contain a fusion RNA with
leader sequence at the 5’ terminus. The leader fragments are thought to
serve as primers for the transcription of the subgenomic RNAs (Lai, 1990).
Leader sequence fragments corresponding to this region are
produced from the 3' end of the negative template (Lai et al., 1982; Spaan et
al., 1983). Priming of subgenomic RNA transcription is mediated through the
binding of the leader to a complementary consensus sequences,
CTT(G)AACAA, found at the 5' end of each individual gene. The consensus
sequence forms the junction between the body of the mRNA and the primer,
that is the leader fragment (Spaan et al., 1983; Baric et al., 1983; Baric et al.,
1985; Makino et al., 1986b).
The nucleocapsid protein of MHV has been found to associate with
the cytosol and membrane-bound small leader RNAs, as well as to
transcription complexes. Also, anti-nucleocapsid monoclonal antibodies
precipitate both full length and subgenomic mRNAs as well replicative
intermediate (Rl) RNAs (Baric et al., 1988a). Baric et al, (1988b) have also
shown that a specific nucleocapsid protein recognition sequence exists in
the small leader-containing RNAs, suggesting that a trans-acting leader
RNA-N complex is involved with mRNA synthesis.
It is known that a number of copies of the nucleocapsid protein of IBV
are associated with the RNA (Schochetman et al., 1977; Oshiro, 1973) and,
as transcription of the negative template is initiated at the 3' end of the
genomic RNA, it seems possible that this is another region where the
nucleocapsid protein should bind and thus play a role in transcription. In
order to investigate the association of the nucleocapsid protein with the 3'
end of the genome, recombinant nucleocapsid protein was produced in E.
coii using the pQE8 expression vector. Its association with RNA from three
different regions of the 3' non-coding region was determined from
northwestern blot analysis and gel-shift assays.
Materials and Methods
Production and purification of recombinant nucleocapsid protein
The nucleocapsid gene was cloned into the pQE8 expression vector,
and the recombinant nucleocapsid protein purified by Ni-NTA affinity
chromatography, as described in chapter IV. The concentrated protein was
quantitated using the Bio Rad protein assay (Bio-Rad), and stored at -100°C
in 10^1 aliquots.
In vitro transcription of IBV strand-specific probes
The in vitro transcripts used in this study were derived from either
pCRIOOO (Invitrogen) or pGem3Z (Promega) plasmids, containing either the
bacterial T7 (in pCRIOOO) or SP6 and T7 (in pGEM3Z) RNA polymerase
initiation sites. Inserts were obtained by cDNA cloning of PCR products
corresponding to the sequences depicted in Fig. 5-1. The PCR primers used
to amplify these regions are listed in Table 5-1. Per was performed, and the
resulting products either cloned into the PCR1000 vector by virtue of the T
overhang resulting from the PCR (clones G2+, G3-, AB+, AB-, CD+, CD-), or
into the pGem3Z vector following restriction enzyme digestion (clones I+/_,
EF+/_), as described in chapter II. The PCR primers were designed with
restriction enzyme recognition sequences at their 5' ends. This enabled 5^g
of the resulting PCR product to be digested with 2units of either BamH1 or
Table5-1.PCRprimersusedtoamplifys ecificregionsofthIBVcDNAfsub-cl ningin otran ription vectors.Restri i nnzymesi sa eshowninbold:GGATCC=BamH1,GAATCC=Ec R1, AAGCTT=Hindlll. CloneUpstreamrimer G2+AATTCCCGCGTGT CC TCTAGT G3-GGATCCGCTCTAACTCTATACTAGCCTAT 1+GAATTCCAGCTTTAGGTGAGAATGAAC I -GGATCCAAGCTACATGCCTATCTCCC AB+GATTCGGGTA G ATGC T AB-GGATCCGCACTGGCATCTTTATACCTACT CD+GGATCCGAGTAGGTATAAAGATGCCAGTG CD-TAGAATACTCAAGCTTGCATGCCTGCCTGCAG EF+GAATTCCGAACGGTAGACCCTTAAGATTTTC EF-GGATCCCCTAGTGGGTGTCCTAGTGTT TADownstreamprim r GGATCCGCTCTAACTCTATACTAGCCTAT GAATTCCCGCGTGTACCTCTCTAGTA GGATCCAAGCTACATGCCTATCTCCC GAATTCCAGCTTTAGGTGAGAATGAAC GGATCCGCACTGGCATCTTTATACCTACT GAATTCGGGAGATAGGCATGTAGCTT TAGAATACTCAAGCTTGCATGCCTGCCTGCAG GGATCCGAGTAGGTATAAAGATGCCAGTG GGATCCCCTAGTGGGTGTCCTAGTGTTGTA GAATTCCGAACGGTAGACCCTTAAGATTTTC
CT)
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Nucleocapsid
Gene
Clones
G2+ T7D
G3- T7D
1 + /-
AB+
AB-
CD+
CD-
EF+/-
3' HVR 3' Non-coding
■AAA 3’
RE
\n sp6
T7 □ 1
T7 □ 1
T7 □
T7 □
T7dj (□ SP6
Fig. 5-1 Diagramatic representation of clones used for in vitro
transcription of IBV-specific RNAs. T7 and SP6= recognition
sequences for bacterial RNA polymerases. | = restriction
enzyme recognition sites for linearization of plasmid DNA.
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Hindlll (Promega corporation, Madison, Wl) in buffer C (50mM NaCI, 10mM
Tris-HCI, pH7.9, 10mM MgCl2, 1mM DTT) or EcoR1 (Promega) in buffer H
(50mM NaCI, 90mM Tris-HCI, pH7.5, 10mM MgCI2, 1mM DTT) at 37°C for
2h. Following the addition of 1/10 volume 10X loading buffer, the reactions
were loaded onto a 0.8% low melting point agarose gel and
electrophoresed at 60V to purify the digested PCR products. The DNA bands
were excised and the agarose melted at 56°C in 10mM Tris-HCI, pH 7.6,
1mM EDTA, pH 8.0 (TE). Following phenol extraction, the DNA was
precipitated with 0.3M NaOAc, pH5.2, and two volumes of ethanol at -20°C
for 2h. Ligation reactions were set up as described in chapter IV and used to
transform electroporation-competent JM109 cells (Stratagene, La Jolla, CA).
Clone G2+ contains the whole of the nucleocapsid gene and the 3'
non-coding region, and G3- is complementary to G2+. I+/- are the positive
and negative sense clones of the 3’ hypervariable region. AB+/-, CD+/- and
EF+/-are the positive and negative sense clones of overlapping regions of
the 3' non-coding region (Fig. 5-1).
Linear templates were obtained by digestion of these clones with
either BamH1 (G2, l+, AB+, CD-, EF+), EcoR1 (G3, I-, AB-, EF+) or Hindlll
(CD+) as previously described, and the products were collected by ethanol
precipitation following phenol extraction. Transcription was carried out in
100pl of reaction buffer containing approximately 1.5pg of linearized
template, 40mM Tri-HCI, pH7.5, 6mM MgCl2, 2mM spermidine, 10mM NaCI,
100 units rRNasin (Promega) 0.5mM each of ATP, GTP, and UTP, 0.1 mM
CTP, 200pCi [a-32P]CTP, and 20 units of either T7 or SP6 RNA polymerase
(Promega, Madison, Wl). Competitor (cold) RNA was made under the same
conditions as the labelled RNA but 0.5mM CTP was used with no
radiolabelled CTP. Following transcription at 37°C for 2h, the DNA template
was removed by incubation with 2.5units DNasel for 15min at 37°C, and
the RNA was extracted with an equal volume of phenol:chloroform:isoamyl
alcohol and precipitated with 0.5 volume 7.5M ammonium acetate and 2
volumes ethanol at -20 overnight. Following centrifugation at 12,000 x g for
20min, the RNA was resuspended in 10jxl RNAse-free dh^O and quantitated
using a spectrophotometer (Biorad). All RNAs were diluted in RNase-free
db^O to a standard concentration of 1ng/|Al.
Northwestern blot analysis
RNA sequences binding to the nucleocapsid protein were detected by
northwestern blot analysis. 3.5|Lig of whole IBV proteins and purified
nucleocapsid protein were separated by electrophoresis on 10% SDS-
PAGE, and transferred to nitrocellulose as described in chapter IV. Before
performing the binding assay, the blots were washed for 30min at room
temperature in SBB buffer (10mM Tris, pFI7, 50mM NaCI, 1mM EDTA, 0.02%
bovine serum albumin, 0.02% Ficoll, and 0.02% polyvinyl pyrrolidone).
Strips of the blots were placed in petri dishes containing 4ml SBB and 2 x
105 cpm of 32P-labelled RNA (that is approximately 10ng RNA). Competitor
RNA (bovine liver RNA) was added to a final concentration of 20^ig/ml to
remove non-specific binding. After 1h at room temperature with constant
agitation, the strips were washed with three changes of SBB and dried, and
the bound RNA was then visualized by autoradiography. Nucleocapsid
protein was also localized on the nitrocellulose strips by western blot
analysis using anti-IBV antisera (Sambrook et ai, 1989).
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Gel-shift analysis
Specific protein-RNA interactions were also analyzed by a gel-shift
assay. One ng of RNA and varying concentrations of nucleocapsid protein
(0.3 x 10'2mg/ml to 4mg/ml) were co-incubated for 20min at room
temperature in 10jil of gel-shift buffer (25mM Hepes, 25mM EDTA, 150mM
NaCI, 5mM DTT, 10% glycerol and 20units rRNasin). Following the addition
of 1pl 10x sample buffer, the reactions were loaded onto a 0.5% agarose gel
and run at 60V in 1XTBE until the bromophenol blue was approximately 1
inch from the end of the gel. The gels were placed into Ziploc bags, wrapped
in aluminium foil together with a film, and visualized by autoradiography.
Competition assays were performed using a constant amount of
nucleocapsid protein (4.2|ig) and labelled RNA (1 ng), with variable amounts
of cold homologous or heterologous competitor RNA (0.4ng to 50ng). Buffer,
dH20 and RNAs were all mixed together first, before the addition of the
proteins to allow the RNAs an equal opportunity to bind to the nucleocapsid
protein. Cache valley virus (CVV) RNA was also used as a competitor to
determine whether the nucleocapsid protein also had a high affinity for other
viral RNAs. This RNA was produced from the transcription of BamH1
digested S segment cDNA in pGEM3Z, supplied by Shan-lng Chung
(Chung, 1992)
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Results
Northwestern and western blots
A northwestern assay was first used in order to determine which RNA
fragments were able to associate with the IBV nucleocapsid protein. The
recombinant nucleocapsid protein and IBV whole viral proteins (used as
controls) were electrophoresed on SDS-PAGE and transferred to
nitrocellulose. Fig. 5-2 shows the results of the northwestern and parallel
western blot of these proteins. The position of the nucleocapsid protein,
migrating at 50kD in both the whole virus and purified recombinant protein
lanes, was verified by western blot analysis. RNA from clone G2+,
corresponding to the nucleocapsid gene through to the 3' end of the IBV
genome, bound to the nucleocapsid protein in the northwestern blot.
However, this RNA was also found to bind to various other proteins in the
virion (Fig. 5-2). For additional northwestern assays a 2x103 molar excess of
competitor RNA, that is 20pg/ml of bovine liver RNA, was used to compete
out non-specific binding of IBV RNA to other proteins. In contrast, even at this
high concentration of competitor RNA, all the positive sense clones (Fig. 5-3)
and negative sense clones (Fig. 5-4) appeared to bind to the nucleocapsid
protein with a greater affinity than the non-IBV RNAs.
Gel-shift analysis
A gel shift assay was developed to determine the relative affinity of
each of the IBV RNAs for the nucleocapsid protein. As long as the protein
concentration was relatively high, a huge complex that could not enter a
0.5% agarose gel was formed when any of the RNA fragments were bound
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o
b > z o
Fig. 5-2 Western blot and Northwestern blot of recombinant
nucleocapsid protein, a) Western blot of whole IBV and
recombinant nucleocapsid protein using polyclonal a-IBV. The
nucleocapsid protein is migrating at approximately 50kD. b)
Northwestern blot of whole IBV and recombinant nucleocapsid
protein with 32P labelled G2+ RNA as the probe.
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Fig. 5-3 Northwestern blot analysis of recombinant nucleocapsid
protein and its binding to positive sense RNAs from the 3' end
of the IBV genome. I+ RNA represents the 3' HVR, and AB+,
CD+, & EF+ represent the remaining portions of the 3' non¬
coding region. N = Nucleocapsid, C = Cell control.
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CD- EF-
N C N C
Fig. 5-4 Northwestern blot analysis of recombinant nucleocapsid
protein and its binding to negative sense RNAs from the 3' end
of the IBV genome. I- represents RNA complementary to the 3’
HVR and AB-, CD- & EF- represent RNAs complementary to the
3' non-coding region. N = Nucleocapsid protein, C = Cell
control.
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to the nucleocapsid protein. However, upon titration of the protein, the
complex was found to migrate into the gel as a smear, rather than as a
discrete band, suggesting that either several copies of the nucleocapsid
protein are able to bind to a single piece of RNA, or that once a protein
molecule is bound to the RNA, other copies of the protein are then able to
bind to the RNA-bound protein. Three examples of this are seen in Fig. 5-5
with RNA from clones G2+, 1+ and CD+. The complexed RNA and protein
can be seen remaining in the wells of the gel. As the protein concentration
was decreased, less complex was observed in the wells while a smear was
found in the middle of the gel and increasing amounts of free RNA at the
bottom of the gel.
Competition assays were set up using the smaller positive sense
RNAs (l+, AB+, CD+ and EF+) and non-IBV RNAs (CVV and bovine liver).
Fig 5-6 shows gels of 1+ RNA competing with other RNAs for the
nucleocapsid protein. The amounts of protein and labelled 1+ RNA were kept
constant while increasing amounts of cold competitor RNA were added.
Approximately 10 to 25 times as much cold competitor RNA from the IBV
positive sense clones examined was needed to compete with the radio-
labelled l+ RNA for binding to the nucleocapsid protein. That is, at these
levels of competitor RNA, the majority of the labelled l+ RNA was free rather
than complexed with the nucleocapsid protein. In contrast, the l+ RNA was
not competed off the nucleocapsid protein by the CVV RNA or the bovine
liver RNA, although the CVV RNA bound to the nucleocapsid protein in
northwestern blots. Even with 50 times as much CVV or bovine liver RNA the
l+ RNA remained complexed with the nucleocapsid protein. This shows a
relatively high affinity of the l+ RNA for the nucleocapsid protein. A similar
Fig.5-5Gel shifta saydemonstr tingthebindingof+,l+dCD+RNAthenucleocapsidproteiat variableproteinconcen ratio s.Ahighrotei :RNArat osthcomplexrema ningint ew llss indicatedbyB.FreRNAsi
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Fig. 5-6. Competition gel shift assay with 32P labelled 1+ RNA competing
with other RNAs for nucleocapsid protein binding. Equal
amounts of 1+ RNA and protein were present in each lane while
the cold competitor RNA concentration ranged from 0.4ng to
50ng.
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Fig. 5-7. Competition gel shift assay with CD+ RNA competing with
other RNAs for nucleocapsid protein binding. Equal amounts of
CD+ RNA and protein were present in each lane while the cold
competitor RNA concentration ranged from 0.4ng to 50ng.
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assay was performed using CD+ RNA, and this too shows a relatively high
affinity of the CD+ RNA for the nucleocapsid protein, as it also is not
competed off by the non-IBV RNAs, that is CVV and bovine liver RNA (Fig. 5-
7). These two figures also demonstrated that within the sensitivity of the
assay the IBV RNAs representing te 3' non-coding region were able to
bindto the nucleocapsid protein with a similar affinity. That is, if one of the
competitor RNAs had a greater affinity than the labelled RNA for the
nucleocapsid protein, we would have seen the labelled protein displaced
with much lower levels of competitor RNA.
Discussion
It has previously been demonstrated that the nucleocapsid protein of
MHV is able to bind specifically to RNA corresponding to the leader
sequence (Stohlman et al., 1988). in this paper we have shown that the
nucleocapsid protein is also able to bind with a relatively high affinity to RNA
corresponding to the 3' end of the IBV genome. The northwestern assay was
optimized using a larger clone corresponding to the nucleocapsid gene
through the entire 3' non-coding region, and the gel shift assay was used to
examine the protein interacting with fragments of the 3' non-coding region.
We have shown that all the IBV RNAs were capable of binding to the
nucleocapsid protein, and apparently with a similar affinity.
Because there are no immediately obvious consensus sequences
repeated in each of these regions, the affinity of the RNA for the
nucleocapsid protein may depend on the overall secondary structure of the
RNA rather than a specific sequence. There are also no sequences of any
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significant homology to other known protein binding sequences. The 3' HVR
transcribed from clone 1+ demonstrated a similar binding affinity for the
nucleocapsid protein as the other IBV RNAs. It is not known if this 3' HVR
was inserted into some strains or deleted from others, but it is obviously not
required by all strains as it is absent in Mass41 (Boursnell et al, 1985).
However, in spite of its distinctly different overall composition and because
the 3' HVR clearly impacts the RNA secondary structure in this region of the
genome, its affinity for the nucleocapsid protein supports the hypothesis that
the nucleocapsid protein recognizes secondary structure rather than primary
sequences.
The nature of the binding of the nucleocapsid protein to RNA is not
clear, but at high protein:RNA ratios, a huge complex is formed that does not
even migrate into a 0.5% agarose gel. Rather than forming discrete bands
when the ratio is lowered, a smear was seen between the free and bound
RNAs. This could be due to either several copies of the nucleocapsid protein
binding at different positions along the RNA or specific binding of the
nucleocapsid protein in a few locations, resulting in subsequent protein-
protein interactions. Protein-protein interactions could result from folding of
the complex bringing several proteins into close proximity to each other such
that they can interact, or from co-operative binding of free nucleocapsid
protein to RNA-bound protein. Co-operative binding is unlikely to be
occurring as this usually results from the specific binding of protein to a
nucleation site, thus enabling other proteins to bind. As the nucleocapsid
protein bound to all the sequences in this study with a similar affinity, there is
unlikely to be a nucleation site in this region of the genome. There is
certainly a high affinity of the nucleocapsid protein for IBV RNA, but a
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specific preferred region was not identified in the sequences at the 3' end of
the genome. The nucleocapsid protein is presumably involved in packaging
of the IBV RNA, and maybe the specific recognition of the leader sequence
is important for packaging while the nucleocapsid protein associates non-
specifically with the remaining RNA.
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CHAPTER VI
DISCUSSION AND CONCLUSION
The nucleocapsid protein of coronaviruses is a major structural
protein in the virion, plays a role in transcription and translation, and is
involved in the induction of T cell mediated immune responses. (Cavanagh,
1983; Compton et al., 1987 and Boots eta!., 1992). The nucleocapsid
protein is variable among the different coronaviruses, but is generally highly
conserved among strains within a species, such as IBV in chickens. The
nucleocapsid protein sequences can also be used to distinguish between
the major coronavirus antigenic groups (Dea et al., 1990). The close
correlation between antigenic grouping from serotyping and from
nucleocapsid protein sequences implies that the spike and nucleocapsid
proteins are evolving parallel to each other within distinct antigenic groups
(Williams et al., 1992).
The branching pattern of the IBV strains in the nucleocapsid protein
phylogenetic tree is not exactly the same as that for the 3' non-coding region
as different roots were selected for producing these trees. However, the
overall grouping is similar as the Holl52 and KB8523 are shown to be more
closely related to each other than to the other strains.
It is still not clear whether the 3' HVR is the result of an insertion or a
deletion event. It is possible that the 3' HVR was present in the original IBV,
from which the Holl52 would have been derived, and then KB8523 may
have been the result of some deletions and mutations, with Ark99, Gray and
Beau being produced from further deletions and/or mutations. In this case
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the absence of the 3' HVR in the Mass41 strain would be explained by one
large deletion or recombination event. Alternatively, Mass41 may have been
derived from the original IBV strain without the 3' HVR, and either the other
strains then picked up variations on this region or the Holl52 was the
progenitor of those strains with this 3' HVR with various recombination or
deletion events in this region leading to the emergence of the other strains. If
the 3' HVR is the result of an insertion, its presence is most likely due to
recombination with the host RNA. In order to verify this hypothesis a genomic
library of chicken mRNA could be screened with probes from the IBV 3’
HVR. Any positive clones would then have to be sequenced and compared
to the 3' HVR.
Future experiments may also be performed to determine if the 3' HVR
is present at this putative recombinational hot spot. Recombination might be
experimentally reproduced by co-infecting chick embryo kidney (CEK) cells
with the Mass41 strain of IBV, and transfecting with an expression vector
containing the 5' non-coding region, the nucleocapsid gene and the 3’ non¬
coding region of the Gray strain. Progeny virus would then be screened for
the presence of the 3' HVR.
Regions of strong homology among these different nucleocapsid
proteins suggest a functional importance in viral replication that even over
time and evolution are very sensitive to change. It is interesting that the
acidic region nearest the amino terminal of IBV includes two regions which
are also very highly conserved among all the coronaviruses. The high
degree of conservation of the nucleocapsid protein could also make it a
valuable diagnostic probe.
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In contrast to the high level of conservation of the nucleocapsid
protein, the adjacent 3' region is highly variable. A high level of
recombination has been reported during the replication of murine
coronaviruses (Lai, 1992), and it is likely that the 3' HVR was inserted into
the 3' non-coding region of many IBV strains as a result of this
recombination. The location of the 3' HVR is conserved at a position
immediately downstream from the stop codon of the nucleocapsid gene but
there is no evidence as yet to show that this HVR has any effect on virulence
or pathogenesis. In contrast, a deletion of approximately 240 amino acids
from the S protein of TGEV is thought to be responsible for the emergence of
PRCV. This deletion resulted in the absence of two antigenic sites in PRCV
isolates and is the basis for their differentiation from the enteropathogenic
TGEV (Sanchez et al., 1992). However, the sequences flanking the 3' end of
the IBV HVR are similar to the tetrameric (TTCC) or heptameric (AGTTTCC)
repeats found within the regions deleted from the PRCVs. It is possible that
the sequences contained in the 3' HVR are not essential for replication, but
they may play an important role in determining the secondary structure of
this region of the genome and thus influence its association with the
replication machinery.
It has previously been demonstrated that the nucleocapsid protein of
coronaviruses is able to bind specifically to RNA corresponding to the leader
sequence (Stohlman et al., 1988). The present studies have shown that the
nucleocapsid protein is also able to bind with high affinity to RNA
corresponding to the 3' end of the IBV genome. All the positive and negative
sense IBV-derived RNAs used in this study were capable of binding to the
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nucleocapsid protein, and apparently all the positive sense IBV RNAs had
similar affinity for the nucleocapsid protein.
The promiscuous affinity of the nucleocapsid protein for IBV
oligonucleotides, and the absence of obvious repeated consensus
sequences in each of these regions, suggests that it is recognizing an
overall secondary structure in the RNA, or sequences with a similar
compostion, rather than a specific sequence. Additionally, there are no
sequences of any significant homology to other known protein binding
sequences, supporting our hypothesis that the protein is recognizing the
RNA secondary structure.
Future experiments should address the potential for phosphorylation
of a recombinant nucleocapsid protein produced in E. coli, because this may
well influence the binding specificity of the nucleocapsid protein with certain
RNA sequences. For example, it has been shown that the removal of a
phosphate group from the avian retrovirus nucleocapsid protein pp12
decreases its affinity for viral RNA 100-fold (Fu et. al., 1985). Experiments
such as site-directed mutagenesis of the nucleocapsid protein gene could
help to define regions important in the binding of the protein to RNA. Shorter
RNA sequences should also be examined to determine whether the protein
binds to specific residues or to a particular secondary structure.
The nucleocapsid protein plays many important roles in the
coronavirus life cycle. It is an integral part of the replication cycle of the virus,
presumably through its interaction with the RNA, and maybe also through
association with other viral proteins. Therefore, further investigation of the
association of the nucleocapsid protein with IBV RNA should help us to
understand more about the coronavirus replication cycle, and ultimately aid
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in development of anti-viral drugs and better control of IBV associated
disease.
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